Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Association of Serum Vitamin D and Total Antioxidant Capacity Levels With Stress and Anxiety in Young Female Students

Samira Hashemi 1 , Reza Amani 2 , 3 , * , Bahman Cheraghian 4 , Sorour Neamatpour 5 and Mohammadreza Afsharmanesh 6
Authors Information
1 Nutrition and Metabolic Disease Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Nutrition, Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Food Security Research Center, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
4 Department of Biostatistics and Epidemiology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 Department of Psychiatry, Golestan Medical Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6 Department of Biochemistry, Hyperlipidaemia Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2017, 11 (2); e7790
  • Published Online: December 19, 2016
  • Article Type: Original Article
  • Received: July 5, 2016
  • Revised: October 18, 2016
  • Accepted: December 9, 2016
  • DOI: 10.5812/ijpbs.7790

To Cite: Hashemi S, Amani R, Cheraghian B, Neamatpour S, Afsharmanesh M. Association of Serum Vitamin D and Total Antioxidant Capacity Levels With Stress and Anxiety in Young Female Students, Iran J Psychiatry Behav Sci. 2017 ; 11(2):e7790. doi: 10.5812/ijpbs.7790.

Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Weinberger DR. Anxiety at the frontier of molecular medicine. N Engl J Med. 2001; 344(16): 1247-9[DOI][PubMed]
  • 2. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998; 280(18): 1569-75[PubMed]
  • 3. Gross C, Hen R. The developmental origins of anxiety. Nat Rev Neurosci. 2004; 5(7): 545-52[DOI][PubMed]
  • 4. Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, et al. An epidemiological survey of psychiatric disorders in Iran. Clin Pract Epidemiol Ment Health. 2005; 1: 16[DOI][PubMed]
  • 5. de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry. 2002; 159(4): 620-9[DOI][PubMed]
  • 6. Issakidis C, Andrews G. Service utilisation for anxiety in an Australian community sample. Soc Psychiatry Psychiatr Epidemiol. 2002; 37(4): 153-63[PubMed]
  • 7. Huang JY, Arnold D, Qiu CF, Miller RS, Williams MA, Enquobahrie DA. Association of serum vitamin D with symptoms of depression and anxiety in early pregnancy. J Womens Health (Larchmt). 2014; 23(7): 588-95[DOI][PubMed]
  • 8. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005; 135(2): 310-6[PubMed]
  • 9. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health. 2004; 4: 38[DOI][PubMed]
  • 10. Eyles DW, Feron F, Cui X, Kesby JP, Harms LH, Ko P, et al. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology. 2009; 34 Suppl 1-57[DOI][PubMed]
  • 11. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J. 2008; 22(4): 982-1001[DOI][PubMed]
  • 12. Stumpf WE, Sar M, Clark SA, DeLuca HF. Brain target sites for 1,25-dihydroxyvitamin D3. Science. 1982; 215(4538): 1403-5[PubMed]
  • 13. Walbert T, Jirikowski GF, Prufer K. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. Horm Metab Res. 2001; 33(9): 525-31[DOI][PubMed]
  • 14. Neveu I, Naveilhan P, Menaa C, Wion D, Brachet P, Garabedian M. Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J Neurosci Res. 1994; 38(2): 214-20[DOI][PubMed]
  • 15. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2007; 10(1): 12-9[DOI][PubMed]
  • 16. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006; 14(12): 1032-40[DOI][PubMed]
  • 17. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys. 2007; 460(2): 202-5[DOI][PubMed]
  • 18. Llewellyn DJ, Langa KM, Lang IA. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol. 2009; 22(3): 188-95[DOI][PubMed]
  • 19. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010; 74(1): 18-26[DOI][PubMed]
  • 20. Hedelin M, Lof M, Olsson M, Lewander T, Nilsson B, Hultman CM, et al. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population. BMC Psychiatry. 2010; 10: 38[DOI][PubMed]
  • 21. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport. 2004; 15(8): 1271-4[PubMed]
  • 22. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res. 2005; 157(2): 299-308[DOI][PubMed]
  • 23. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007; 26(4): 551-4[DOI][PubMed]
  • 24. Dean AJ, Bellgrove MA, Hall T, Phan WM, Eyles DW, Kvaskoff D, et al. Effects of vitamin D supplementation on cognitive and emotional functioning in young adults--a randomised controlled trial. PLoS One. 2011; 6(11)[DOI][PubMed]
  • 25. Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology. 2002; 46(1): 27-32[PubMed]
  • 26. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39(1): 44-84[DOI][PubMed]
  • 27. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008; 11(6): 851-76[DOI][PubMed]
  • 28. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006; 97(6): 1634-58[DOI][PubMed]
  • 29. Delattre J, Beaudeux JL, Bonnefont-Rousselot D. Radicaux libres et stress oxydant(aspects biologiques et pathologiques). 2005;
  • 30. Filiou MD, Zhang Y, Teplytska L, Reckow S, Gormanns P, Maccarrone G, et al. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol Psychiatry. 2011; 70(11): 1074-82[DOI][PubMed]
  • 31. Mazloom Z, Ekramzadeh M, Hejazi N. Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebo-controlled trial. Pak J Biol Sci. 2013; 16(22): 1597-600[PubMed]
  • 32. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995; 33(3): 335-43[PubMed]
  • 33. Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005; 44: 227-39[DOI][PubMed]
  • 34. Crawford JR, Henry JD. The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol. 2003; 42: 111-31[DOI][PubMed]
  • 35. Maddock J, Berry DJ, Geoffroy MC, Power C, Hypponen E. Vitamin D and common mental disorders in mid-life: cross-sectional and prospective findings. Clin Nutr. 2013; 32(5): 758-64[DOI][PubMed]
  • 36. van der Schaft J, Koek HL, Dijkstra E, Verhaar HJ, van der Schouw YT, Emmelot-Vonk MH. The association between vitamin D and cognition: a systematic review. Ageing Res Rev. 2013; 12(4): 1013-23[DOI][PubMed]
  • 37. Chei CL, Raman P, Yin ZX, Shi XM, Zeng Y, Matchar DB. Vitamin D levels and cognition in elderly adults in China. J Am Geriatr Soc. 2014; 62(11): 2125-9[DOI][PubMed]
  • 38. Millet P, Landel V, Virard I, Morello M, Feron F. [Role of vitamin D in the physiopathology of neurodegenerative diseases]. Biol Aujourdhui. 2014; 208(1): 77-88[DOI][PubMed]
  • 39. Thouvenot E, Camu W. [Vitamin D and neurology]. Presse Med. 2013; 42(10): 1398-404[DOI][PubMed]
  • 40. Gowda U, Mutowo MP, Smith BJ, Wluka AE, Renzaho AM. Vitamin D supplementation to reduce depression in adults: meta-analysis of randomized controlled trials. Nutrition. 2015; 31(3): 421-9[DOI][PubMed]
  • 41. Sanders KM, Stuart AL, Williamson EJ, Jacka FN, Dodd S, Nicholson G, et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry. 2011; 198(5): 357-64[DOI][PubMed]
  • 42. Guney E, Fatih Ceylan M, Tektas A, Alisik M, Ergin M, Goker Z, et al. Oxidative stress in children and adolescents with anxiety disorders. J Affect Disord. 2014; 156: 62-6[DOI][PubMed]
  • 43. Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res. 2010; 68(4): 261-75[DOI][PubMed]
  • 44. Bouayed J, Rammal H, Soulimani R. Oxidative stress and anxiety: relationship and cellular pathways. Oxid Med Cell Longev. 2009; 2(2): 63-7[PubMed]
  • 45. Bouayed J. Polyphenols: A Potential New Strategy for the Prevention and Treatment of Anxiety and Depression. Curr Nutr Food Sci. 2010; 6(1): 13-8[DOI]
  • 46. Macht M, Mueller J. Immediate effects of chocolate on experimentally induced mood states. Appetite. 2007; 49(3): 667-74[DOI][PubMed]
  • 47. Zellner DA, Loaiza S, Gonzalez Z, Pita J, Morales J, Pecora D, et al. Food selection changes under stress. Physiol Behav. 2006; 87(4): 789-93[DOI][PubMed]
  • 48. Christensen L, Brooks A. Changing food preference as a function of mood. J Psychol. 2006; 140(4): 293-306[DOI][PubMed]
  • 49. Crichton GE, Murphy KJ, Bryan J. Dairy intake and cognitive health in middle-aged South Australians. Asia Pac J Clin Nutr. 2010; 19(2): 161-71[PubMed]
  • 50. Sanchez-Villegas A, Verberne L, De Irala J, Ruiz-Canela M, Toledo E, Serra-Majem L, et al. Dietary fat intake and the risk of depression: the SUN Project. PLoS One. 2011; 6(1)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments